Table 1.
Characteristics of the 20 NPC patients who developed unilateral temporal lobe injury
| Case | Gender | Age (years) | T stage* | Stage* | OTT (days) | CT | TLI latency (months) |
|---|---|---|---|---|---|---|---|
| 1 |
male |
54 |
3 |
III |
38 |
yes |
40.27 |
| 2 |
male |
40 |
4 |
IVa |
41 |
yes |
25.77 |
| 3 |
male |
54 |
4 |
IVa |
41 |
yes |
31.47 |
| 4 |
male |
42 |
4 |
IVa |
39 |
yes |
35.37 |
| 5 |
male |
37 |
4 |
IVa |
78 |
yes |
38.13 |
| 6 |
male |
55 |
3 |
III |
47 |
yes |
35.57 |
| 7 |
male |
40 |
4 |
IVa |
38 |
yes |
25.13 |
| 8 |
male |
39 |
4 |
IVa |
46 |
yes |
25.40 |
| 9 |
male |
43 |
4 |
IVa |
46 |
yes |
27.27 |
| 10 |
male |
36 |
3 |
III |
48 |
yes |
37.90 |
| 11 |
female |
25 |
4 |
IVa |
40 |
yes |
26.40 |
| 12 |
male |
50 |
4 |
IVa |
42 |
yes |
31.90 |
| 13 |
male |
44 |
4 |
IVa |
44 |
yes |
25.13 |
| 14 |
male |
43 |
4 |
IVa |
38 |
yes |
27.17 |
| 15 |
male |
41 |
4 |
IVa |
39 |
yes |
48.43 |
| 16 |
male |
52 |
2 |
II |
42 |
no |
27.67 |
| 17 |
female |
34 |
4 |
IVa |
45 |
yes |
46.33 |
| 18 |
female |
33 |
4 |
IVa |
49 |
yes |
44.70 |
| 19 |
male |
52 |
1 |
I |
40 |
no |
50.70 |
| 20 | female | 51 | 4 | IVa | 43 | yes | 56.87 |
Abbreviations: OTT Overall treatment time, CT Chemotherapy.
*According to the American Joint Committee on Cancer, 7th edition.